National Institute on Drug Abuse (NIDA): Heroin Dependence trials

The registry lists 14 Heroin Dependence studies with National Institute on Drug Abuse (NIDA) as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 5Phase 3 2Phase 4 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Buspirone in Opiate WithdrawalCompletedNCT00326235Phase 4
• Effect of Clonidine on Responses to Imagery ScriptsCompletedNCT00318760Phase 1
• Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1CompletedNCT00249574Not applicable
• Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1CompletedNCT00218530Phase 1
• Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent IndividualsCompletedNCT00218309
• Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing RegimensCompletedNCT00218127Phase 2
• The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1CompletedNCT00158288Phase 2
• Addition of Naltrexone to Methadone TaperCompletedNCT00135759Phase 2
• Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14CompletedNCT00015340Phase 4
• Buprenorphine and Naloxone Combination Study - 10CompletedNCT00015288Phase 1
• Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1CompletedNCT00015171Phase 3
• Study Comparing Liquid and Tablet Buprenorphine Formulations - 5CompletedNCT00000302Phase 3
• Treatment Efficacy for Drug Abuse and AIDS Prevention - 2CompletedNCT00000211Phase 2
• Treatment Efficacy for Drug Abuse and AIDS Prevention - 1CompletedNCT00000210Phase 2